Lilly Zepbound / Mounjaro (tirzepatide) ~21% mean weight loss at ~72 weeks (top dose) Clear superiority vs Wegovy Growing long-term durability data Takeaway: Zepbound remains the benchmark every obesity drug must beat or meaningfully out-differentiate
TRIUMPH-CVOT: cardiovascular outcomes trial, approximately 10,000 participants with established CVD, primary endpoint major adverse cardiovascular events (MACE), timeline 3 to 4 years
The equivalence of oral and injectable routes in terms of systemic exposure and target tissue concentration has not been established in any human study
A more recent large-scale prospective study showed that people in the highest quintile of UA were associated with a 25% (HR, 0.75
Concurrently, elevated p-tau levels induce reactive ROS overproduction and enhance GTPase activity of Drp1, directly driving pathological mitochondrial hyperfission and functional collapse in neurons (Pradeepkiran and Reddy, 2020)
10.1016/j.envres.2015.06.011 95
